Fig. 2From: SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case reportCutaneous lesions on the face, back and sternal region before (upside) and after (downside) ADA treatmentBack to article page